EC Number | Application | Comment | Organism |
---|---|---|---|
4.4.1.11 | medicine | utilization for the treatment of cancers | Arabidopsis thaliana |
4.4.1.11 | medicine | utilization for the treatment of cancers | Entamoeba histolytica |
4.4.1.11 | medicine | utilization for the treatment of cancers | Pseudomonas putida |
4.4.1.11 | medicine | utilization for the treatment of cancers | Brevibacterium linens |
4.4.1.11 | medicine | utilization for the treatment of cancers | Fusobacterium nucleatum |
4.4.1.11 | medicine | utilization for the treatment of cancers | Porphyromonas gingivalis |
4.4.1.11 | medicine | utilization for the treatment of cancers | Prevotella denticola |
4.4.1.11 | medicine | utilization for the treatment of cancers | Trichomonas vaginalis |
EC Number | Crystallization (Comment) | Organism |
---|---|---|
4.4.1.11 | - |
Arabidopsis thaliana |
4.4.1.11 | - |
Entamoeba histolytica |
4.4.1.11 | - |
Pseudomonas putida |
4.4.1.11 | - |
Brevibacterium linens |
4.4.1.11 | - |
Fusobacterium nucleatum |
4.4.1.11 | - |
Porphyromonas gingivalis |
4.4.1.11 | - |
Prevotella denticola |
4.4.1.11 | - |
Trichomonas vaginalis |
EC Number | Protein Variants | Comment | Organism |
---|---|---|---|
4.4.1.11 | C116H | increase of enzyme activity toward cysteine, decrease of enzyme activity toward methionine | Pseudomonas putida |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
4.4.1.11 | myrsinoic acid B | - |
Fusobacterium nucleatum | |
4.4.1.11 | myrsinoic acid B | - |
Porphyromonas gingivalis | |
4.4.1.11 | myrsinoic acid B | - |
Prevotella denticola |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
4.4.1.11 | Arabidopsis thaliana | - |
- |
- |
4.4.1.11 | Brevibacterium linens | - |
- |
- |
4.4.1.11 | Entamoeba histolytica | - |
- |
- |
4.4.1.11 | Fusobacterium nucleatum | - |
- |
- |
4.4.1.11 | Porphyromonas gingivalis | - |
- |
- |
4.4.1.11 | Prevotella denticola | - |
- |
- |
4.4.1.11 | Pseudomonas putida | - |
- |
- |
4.4.1.11 | Trichomonas vaginalis | O15564 | - |
- |
4.4.1.11 | Trichomonas vaginalis | O15565 | - |
- |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
4.4.1.11 | seed | - |
Arabidopsis thaliana | - |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
4.4.1.11 | EhMGL1 | - |
Entamoeba histolytica |
4.4.1.11 | EhMGL2 | - |
Entamoeba histolytica |
4.4.1.11 | methionine gamma-lyase | - |
Arabidopsis thaliana |
4.4.1.11 | methionine gamma-lyase | - |
Entamoeba histolytica |
4.4.1.11 | methionine gamma-lyase | - |
Pseudomonas putida |
4.4.1.11 | methionine gamma-lyase | - |
Brevibacterium linens |
4.4.1.11 | methionine gamma-lyase | - |
Fusobacterium nucleatum |
4.4.1.11 | methionine gamma-lyase | - |
Porphyromonas gingivalis |
4.4.1.11 | methionine gamma-lyase | - |
Prevotella denticola |
4.4.1.11 | methionine gamma-lyase | - |
Trichomonas vaginalis |
4.4.1.11 | TvMGL1 | - |
Trichomonas vaginalis |
4.4.1.11 | TvMGL2 | - |
Trichomonas vaginalis |
EC Number | IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|---|
4.4.1.11 | 0.000389 | - |
- |
Fusobacterium nucleatum | myrsinoic acid B | |
4.4.1.11 | 0.0303 | - |
- |
Prevotella denticola | myrsinoic acid B | |
4.4.1.11 | 0.0824 | - |
- |
Porphyromonas gingivalis | myrsinoic acid B |
EC Number | Organism | Comment | Expression |
---|---|---|---|
4.4.1.11 | Arabidopsis thaliana | higher expression in imbibed seeds | up |
4.4.1.11 | Brevibacterium linens | upregulation under methionine-rich conditions | up |
EC Number | General Information | Comment | Organism |
---|---|---|---|
4.4.1.11 | physiological function | involvled in pathogenicity of periodontal bacterium | Porphyromonas gingivalis |
4.4.1.11 | physiological function | isoleucine biosynthesis, sulfur storage, involved in the alternative reverse-transsulfuration pathway, important roe in the resumption process | Arabidopsis thaliana |